NCT06315322 - A Study to Test the Long-term Safety and Tolerability of Brivaracetam in Study Participants With Childhood Absence Epilepsy or Juvenile Absence Epilepsy | Biotech Hunter

Enrollment

120

Participants

Timeline

Start Date

July 10, 2024

Primary Completion Date

March 1, 2030

Study Completion Date

March 1, 2030

Conditions

Childhood Absence EpilepsyJuvenile Absence Epilepsy

Interventions

DRUG

Brivaracetam Film-coated tablet

Drug: Brivaracetam Film-coated tablet Pharmaceutical form: Film-coated tablet Route of administration: Oral use Brivaracetam film-coated tablet \[10, 25 or 50 mg\] will be administered twice per day in equal doses.

DRUG

Brivaracetam oral solution

Pharmaceutical form: Oral solution Route of administration: Oral use Brivaracetam oral solution \[10 mg/mL\]) will be administered twice per day in equal doses.

Trial Locations (23)

27157

RECRUITING

Ep0224 50640, Winston-Salem

33155

RECRUITING

Ep0224 50268, Miami

92868

RECRUITING

Ep0224 50639, Orange

35233-2110

RECRUITING

Ep0224 50140, Birmingham

08901

RECRUITING

Ep0224 50638, New Brunswick

Unknown

RECRUITING

Ep0224 20321, Tbilisi

RECRUITING

Ep0224 20322, Tbilisi

RECRUITING

Ep0224 20323, Tbilisi

RECRUITING

Ep0224 20324, Tbilisi

RECRUITING

Ep0224 40144, Abbiategrasso

RECRUITING

Ep0224 40765, Messina

RECRUITING

Ep0224 40764, Pavia

RECRUITING

Ep0224 40629, Roma

RECRUITING

Ep0224 40766, Roma

RECRUITING

Ep0224 40763, Verona

RECRUITING

Ep0224 40767, Bucharest

RECRUITING

Ep0224 40769, Bucharest

RECRUITING

Ep0224 40768, Iași

RECRUITING

Ep0224 40770, Timișoara

RECRUITING

Ep0224 40771, Bardejov

RECRUITING

Ep0224 40772, Dubnica nad Váhom

RECRUITING

Ep0224 40453, Terrassa

RECRUITING

Ep0224 20328, Uzhhorod

All Listed Sponsors

lead

UCB Biopharma SRL

INDUSTRY